Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare CVE:DYATSE:GUDNYSE:MROBATS:SMIN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDYAdynaCERTC$0.74+7.2%C$0.74C$0.27▼C$1.25C$264.50MN/A1.14 million shs1.80 million shsGUDKnight TherapeuticsC$6.00+2.9%C$5.89C$5.09▼C$6.45C$606.90M0.567,223 shs50,813 shsMROMarathon Oil$28.55$28.18$25.54▼$29.74$15.97B2.165.92 million shsN/ASMINiShares MSCI India Small-Cap ETF$76.87+7.2%$73.48$61.54▼$87.06$865.20M0.48238,816 shs201,805 shs10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDYAdynaCERT0.00%0.00%0.00%0.00%0.00%GUDKnight Therapeutics+2.92%+4.17%+4.35%-1.64%+4.90%MROMarathon Oil0.00%0.00%0.00%0.00%-0.10%SMINiShares MSCI India Small-Cap ETF-0.17%+1.33%+2.26%+11.74%-6.39%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDYAdynaCERTN/AN/AN/AN/AN/AN/AN/AN/AGUDKnight Therapeutics1.4785 of 5 stars2.80.00.00.01.71.70.6MROMarathon Oil0.7167 of 5 stars1.20.02.50.00.61.71.3SMINiShares MSCI India Small-Cap ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDYAdynaCERT 0.00N/AN/AN/AGUDKnight Therapeutics 3.50Strong BuyC$7.1519.17% UpsideMROMarathon Oil 2.40Hold$30.506.83% UpsideSMINiShares MSCI India Small-Cap ETF 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest SMIN, MRO, WEIR, GUD, and DYA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/9/2025GUDKnight TherapeuticsCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetHold ➝ BuyC$6.50(Data available from 7/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDYAdynaCERTC$1.37M192.51C$0.04 per share17.25C$0.06 per share13.45GUDKnight TherapeuticsC$348.70M1.74C$1.56 per share3.85C$7.65 per share0.78MROMarathon Oil$6.70B2.38$6.49 per share4.40$20.44 per share1.40SMINiShares MSCI India Small-Cap ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDYAdynaCERTN/A-C$0.04N/A∞N/AN/AN/AN/AN/AGUDKnight Therapeutics-C$30.73M-C$0.30N/A∞N/A-8.81%-4.04%0.51%N/AMROMarathon Oil$1.55B$2.3312.2512.92N/A19.73%12.80%7.35%N/ASMINiShares MSCI India Small-Cap ETFN/AN/A25.85∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDYAdynaCERTN/AN/AN/AN/AN/AGUDKnight TherapeuticsN/AN/AN/AN/AN/AMROMarathon Oil$0.441.54%N/A18.88%2 YearsSMINiShares MSCI India Small-Cap ETF$5.236.80%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDYAdynaCERT1.7711.338.76GUDKnight Therapeutics7.523.361.79MROMarathon Oil0.400.690.61SMINiShares MSCI India Small-Cap ETFN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDYAdynaCERTN/AGUDKnight Therapeutics12.58%MROMarathon Oil77.24%SMINiShares MSCI India Small-Cap ETFN/AInsider OwnershipCompanyInsider OwnershipDYAdynaCERTN/AGUDKnight Therapeutics45.62%MROMarathon Oil0.35%SMINiShares MSCI India Small-Cap ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDYAdynaCERTN/A357.44 millionN/ANot OptionableGUDKnight Therapeutics725101.15 millionN/ANot OptionableMROMarathon Oil1,681559.41 million557.45 millionOptionableSMINiShares MSCI India Small-Cap ETFN/A12.20 millionN/ANot OptionableSMIN, MRO, WEIR, GUD, and DYA HeadlinesRecent News About These CompaniesBofA’s Hartnett: Buy lagging India stocksMarch 7, 2025 | msn.comSMIN: Keep The Faith In India's Small CapsFebruary 22, 2025 | seekingalpha.com(SMIN) Trading ReportJanuary 30, 2025 | news.stocktradersdaily.comNLong Term Trading Analysis for (SMIN)January 8, 2025 | news.stocktradersdaily.comN(SMIN) Trading AdviceNovember 17, 2024 | news.stocktradersdaily.comNSMIN: High Growth-High Price, Spotting A Better Entry (Rating Downgrade)November 12, 2024 | seekingalpha.com(SMIN) Long Term Investment AnalysisOctober 26, 2024 | news.stocktradersdaily.comNDisruptive Theme of the Week: Digital IndiaOctober 18, 2024 | etftrends.comESMIN: Small-Cap India Outperforms LargeAugust 31, 2024 | seekingalpha.com(SMIN) Investment AnalysisAugust 18, 2024 | news.stocktradersdaily.comNCompare with iShares MSCI India Small-Cap ETF (SMIN)August 15, 2024 | msn.comiShares MSCI World Small Cap UCITS ETF USD (Acc) (WLDS)August 2, 2024 | fidelity.co.ukFArtisan Small Cap Fund Has Deemed Super Micro Computer (SMCI) as not InvestableJuly 30, 2024 | msn.com(SMIN) Technical DataJuly 26, 2024 | news.stocktradersdaily.comNDelta Air Lines, Interactive Brokers And More: CNBC's 'Final Trades'July 24, 2024 | msn.comBest Performing ETFs by Sector in the Past 30 DaysJuly 2, 2024 | zacks.comModi's shock election hits India ETFsJune 4, 2024 | foxbusiness.comIndia ETFs to Soar on Likely Modi WinJune 3, 2024 | zacks.comETF Prime: Chang on Vanguard's CEO, Global Flows, and MoreMay 21, 2024 | etftrends.comEAcross the Pond: Global ETF Flows Going StrongMay 8, 2024 | etftrends.comENew MarketBeat Followers Over TimeMedia Sentiment Over TimeSMIN, MRO, WEIR, GUD, and DYA Company DescriptionsdynaCERT CVE:DYAC$0.74 +0.05 (+7.25%) As of 07/6/2020DynaCERT Inc. engages in the design, engineering, manufacture, testing, distribution, and installation of transportable hydrogen generator aftermarket products in North America and internationally. Its patent-pending retrofit product provides performance enhancements by injecting hydrogen and oxygen into the air intake manifold resulting in fuel efficiency and reduced fuel emissions. The company's principal product is HydraGen, an aftermarket unit that produces hydrogen and oxygen on demand and is designed for on-road applications with class 6-8 engines. It serves on-road vehicles, reefer trailers, mining and forestry equipment, marine vessels, and railroad locomotives, as well as off-road construction and power generation sectors. The company was formerly known as Dynamic Fuel Systems, Inc. and changed its name to DynaCERT Inc. in January 2013. DynaCERT Inc. was founded in 2001 and is headquartered in Toronto, Canada.Knight Therapeutics TSE:GUDC$6.00 +0.17 (+2.92%) As of 07/2/2025 04:00 PM EasternKnight Therapeutics Inc. develops, manufactures, acquires, in-licenses, out-licenses, markets, and distributes pharmaceutical and consumer health products, and medical devices worldwide. It offers Tafasitamab for relapsed or refractory diffuse large B-cell lymphoma; Pemigatinib for metastatic cholangiocarcinoma; Akynzeo for prevention of chemotherapy-induced acute and delayed nausea and vomiting; Aloxi for prevention of acute nausea and vomiting associated with emetogenic cancer chemotherapy; Fostamatinib for chronic immune thrombocytopenia; Nerlynx for extended adjuvant breast cancer and metastatic breast cancer; Trelstar for advanced prostate cancer; Vidaza for myelodysplastic syndrome; Abraxane for metastatic pancreatic cancer; Halaven for metastatic breast cancer and soft tissue sarcoma; and Lenvima for advanced renal cell cancer and for differentiated thyroid cancer and unresectable hepatocellular carcinoma. The company provides Ladecvina for multiple myeloma and myelodysplastic syndrome, mantle cell lymphoma, and follicular lymphoma; Zyvalix for metastatic prostate cancer; Karfib for relapsed or refractory multiple myeloma; Leprid for advanced prostate cancer; Rembre for chronic myeloid leukemia; Palbocil for breast cancer; Ambisome and Cresemba for fungal infection; Impavido for leishmaniasis; Dolufevir for HIV infection; Exelon for dementia; and Ibsrela for irritable bowel syndrome with constipation. In addition, it offers Salofalk for ulcerative colitis; Ursofalk for biliary cirrhosis; Imvexxy for moderate to severe dyspareunia; Bijuva for vasomotor symptoms; Fibridoner for idiopathic pulmonary fibrosis; Toliscrin DPI for pseudomonas aeruginosa lung infection; Toliscrin 1-2 for severe acute or resistant chronic infections; and Tobradosa Haler for chronic lung infections. Further, it finances other life science companies; and invests in life sciences venture capital funds. The company was incorporated in 2013 and is headquartered in Montreal, Canada.Marathon Oil NYSE:MROMarathon Oil Corporation, an independent exploration and production company, engages in exploration, production, and marketing of crude oil and condensate, natural gas liquids, and natural gas in the United States and internationally. The company also produces and markets products manufactured from natural gas, such as liquefied natural gas and methanol. In addition, it owns and operates Sugarloaf gathering system, a natural gas pipeline. The company was formerly known as USX Corporation and changed its name to Marathon Oil Corporation in December 2001. Marathon Oil Corporation was founded in 1887 and is headquartered in Houston, Texas.iShares MSCI India Small-Cap ETF BATS:SMIN$76.87 +5.18 (+7.23%) Closing price 07/2/2025 03:59 PM EasternExtended Trading$76.76 -0.11 (-0.14%) As of 07/2/2025 06:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The iShares MSCI India Small-Cap ETF (SMIN) is an exchange-traded fund that is based on the MSCI India Small Cap index, a market-cap-weighted index of the bottom 14% of companies traded on Indian stock markets. SMIN was launched on Feb 8, 2012 and is managed by BlackRock. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Insider Selling at NVIDIA Could Turn Into an Opportunity Whiplash for Investors: AeroVironment's Confusing Stock Signals Rocket Lab: Latest Catalysts Bolster the Bull Case Nike's Stock Just Got an Upgrade: Is a Real Comeback Brewing? Jefferies Raises Broadcom Price Target to $315: 19% Upside Ahead Dan Ives’ Bold $5 Trillion Forecast for Microsoft Stock 3 Utility Stocks That Combine Income and Stability 2 Reasons to Buy Trade Desk Stock Now and 1 Warning Sign Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
